The global market for Riboflavin Kinase is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Riboflavin Kinase market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Riboflavin Kinase market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Riboflavin Kinase market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Riboflavin Kinase market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Riboflavin Kinase players cover DSM, BASF, NB Group, Shanghai Acebright Pharmaceuticals and Hubei Guangji Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Riboflavin Kinase market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Riboflavin Kinase market, with both quantitative and qualitative data, to help readers understand how the Riboflavin Kinase market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Tons.
Market Segmentation:
The study segments the Riboflavin Kinase market and forecasts the market size by Type (Feed Grade, Food Grade and Pharma Grade), by Application (Food Additives, Animal Feeding, Pharmaceutical and Health Supplements), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Feed Grade
Food Grade
Pharma Grade
Segmentation by application
Food Additives
Animal Feeding
Pharmaceutical
Health Supplements
Cosmetic And Personal Care
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
DSM
BASF
NB Group
Shanghai Acebright Pharmaceuticals
Hubei Guangji Pharmaceutical
Ningxia Qiyuan Pharma
Hebei Shengxue Dacheng
Xinfa Pharmaceutical
Chapter Introduction
Chapter 1: Scope of Riboflavin Kinase, Research Methodology, etc.
Chapter 2: Executive Summary, global Riboflavin Kinase market size (sales and revenue) and CAGR, Riboflavin Kinase market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Riboflavin Kinase sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Riboflavin Kinase sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Riboflavin Kinase market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including DSM, BASF, NB Group, Shanghai Acebright Pharmaceuticals, Hubei Guangji Pharmaceutical, Ningxia Qiyuan Pharma, Hebei Shengxue Dacheng and Xinfa Pharmaceutical, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Riboflavin Kinase Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Riboflavin Kinase by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Riboflavin Kinase by Country/Region, 2017, 2022 & 2028
2.2 Riboflavin Kinase Segment by Type
2.2.1 Feed Grade
2.2.2 Food Grade
2.2.3 Pharma Grade
2.3 Riboflavin Kinase Sales by Type
2.3.1 Global Riboflavin Kinase Sales Market Share by Type (2017-2022)
2.3.2 Global Riboflavin Kinase Revenue and Market Share by Type (2017-2022)
2.3.3 Global Riboflavin Kinase Sale Price by Type (2017-2022)
2.4 Riboflavin Kinase Segment by Application
2.4.1 Food Additives
2.4.2 Animal Feeding
2.4.3 Pharmaceutical
2.4.4 Health Supplements
2.4.5 Cosmetic And Personal Care
2.4.6 Others
2.5 Riboflavin Kinase Sales by Application
2.5.1 Global Riboflavin Kinase Sale Market Share by Application (2017-2022)
2.5.2 Global Riboflavin Kinase Revenue and Market Share by Application (2017-2022)
2.5.3 Global Riboflavin Kinase Sale Price by Application (2017-2022)
3 Global Riboflavin Kinase by Company
3.1 Global Riboflavin Kinase Breakdown Data by Company
3.1.1 Global Riboflavin Kinase Annual Sales by Company (2020-2022)
3.1.2 Global Riboflavin Kinase Sales Market Share by Company (2020-2022)
3.2 Global Riboflavin Kinase Annual Revenue by Company (2020-2022)
3.2.1 Global Riboflavin Kinase Revenue by Company (2020-2022)
3.2.2 Global Riboflavin Kinase Revenue Market Share by Company (2020-2022)
3.3 Global Riboflavin Kinase Sale Price by Company
3.4 Key Manufacturers Riboflavin Kinase Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Riboflavin Kinase Product Location Distribution
3.4.2 Players Riboflavin Kinase Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Riboflavin Kinase by Geographic Region
4.1 World Historic Riboflavin Kinase Market Size by Geographic Region (2017-2022)
4.1.1 Global Riboflavin Kinase Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Riboflavin Kinase Annual Revenue by Geographic Region
4.2 World Historic Riboflavin Kinase Market Size by Country/Region (2017-2022)
4.2.1 Global Riboflavin Kinase Annual Sales by Country/Region (2017-2022)
4.2.2 Global Riboflavin Kinase Annual Revenue by Country/Region
4.3 Americas Riboflavin Kinase Sales Growth
4.4 APAC Riboflavin Kinase Sales Growth
4.5 Europe Riboflavin Kinase Sales Growth
4.6 Middle East & Africa Riboflavin Kinase Sales Growth
5 Americas
5.1 Americas Riboflavin Kinase Sales by Country
5.1.1 Americas Riboflavin Kinase Sales by Country (2017-2022)
5.1.2 Americas Riboflavin Kinase Revenue by Country (2017-2022)
5.2 Americas Riboflavin Kinase Sales by Type
5.3 Americas Riboflavin Kinase Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Riboflavin Kinase Sales by Region
6.1.1 APAC Riboflavin Kinase Sales by Region (2017-2022)
6.1.2 APAC Riboflavin Kinase Revenue by Region (2017-2022)
6.2 APAC Riboflavin Kinase Sales by Type
6.3 APAC Riboflavin Kinase Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Riboflavin Kinase by Country
7.1.1 Europe Riboflavin Kinase Sales by Country (2017-2022)
7.1.2 Europe Riboflavin Kinase Revenue by Country (2017-2022)
7.2 Europe Riboflavin Kinase Sales by Type
7.3 Europe Riboflavin Kinase Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Riboflavin Kinase by Country
8.1.1 Middle East & Africa Riboflavin Kinase Sales by Country (2017-2022)
8.1.2 Middle East & Africa Riboflavin Kinase Revenue by Country (2017-2022)
8.2 Middle East & Africa Riboflavin Kinase Sales by Type
8.3 Middle East & Africa Riboflavin Kinase Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Riboflavin Kinase
10.3 Manufacturing Process Analysis of Riboflavin Kinase
10.4 Industry Chain Structure of Riboflavin Kinase
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Riboflavin Kinase Distributors
11.3 Riboflavin Kinase Customer
12 World Forecast Review for Riboflavin Kinase by Geographic Region
12.1 Global Riboflavin Kinase Market Size Forecast by Region
12.1.1 Global Riboflavin Kinase Forecast by Region (2023-2028)
12.1.2 Global Riboflavin Kinase Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Riboflavin Kinase Forecast by Type
12.7 Global Riboflavin Kinase Forecast by Application
13 Key Players Analysis
13.1 DSM
13.1.1 DSM Company Information
13.1.2 DSM Riboflavin Kinase Product Offered
13.1.3 DSM Riboflavin Kinase Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 DSM Main Business Overview
13.1.5 DSM Latest Developments
13.2 BASF
13.2.1 BASF Company Information
13.2.2 BASF Riboflavin Kinase Product Offered
13.2.3 BASF Riboflavin Kinase Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 BASF Main Business Overview
13.2.5 BASF Latest Developments
13.3 NB Group
13.3.1 NB Group Company Information
13.3.2 NB Group Riboflavin Kinase Product Offered
13.3.3 NB Group Riboflavin Kinase Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 NB Group Main Business Overview
13.3.5 NB Group Latest Developments
13.4 Shanghai Acebright Pharmaceuticals
13.4.1 Shanghai Acebright Pharmaceuticals Company Information
13.4.2 Shanghai Acebright Pharmaceuticals Riboflavin Kinase Product Offered
13.4.3 Shanghai Acebright Pharmaceuticals Riboflavin Kinase Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Shanghai Acebright Pharmaceuticals Main Business Overview
13.4.5 Shanghai Acebright Pharmaceuticals Latest Developments
13.5 Hubei Guangji Pharmaceutical
13.5.1 Hubei Guangji Pharmaceutical Company Information
13.5.2 Hubei Guangji Pharmaceutical Riboflavin Kinase Product Offered
13.5.3 Hubei Guangji Pharmaceutical Riboflavin Kinase Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Hubei Guangji Pharmaceutical Main Business Overview
13.5.5 Hubei Guangji Pharmaceutical Latest Developments
13.6 Ningxia Qiyuan Pharma
13.6.1 Ningxia Qiyuan Pharma Company Information
13.6.2 Ningxia Qiyuan Pharma Riboflavin Kinase Product Offered
13.6.3 Ningxia Qiyuan Pharma Riboflavin Kinase Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Ningxia Qiyuan Pharma Main Business Overview
13.6.5 Ningxia Qiyuan Pharma Latest Developments
13.7 Hebei Shengxue Dacheng
13.7.1 Hebei Shengxue Dacheng Company Information
13.7.2 Hebei Shengxue Dacheng Riboflavin Kinase Product Offered
13.7.3 Hebei Shengxue Dacheng Riboflavin Kinase Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Hebei Shengxue Dacheng Main Business Overview
13.7.5 Hebei Shengxue Dacheng Latest Developments
13.8 Xinfa Pharmaceutical
13.8.1 Xinfa Pharmaceutical Company Information
13.8.2 Xinfa Pharmaceutical Riboflavin Kinase Product Offered
13.8.3 Xinfa Pharmaceutical Riboflavin Kinase Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Xinfa Pharmaceutical Main Business Overview
13.8.5 Xinfa Pharmaceutical Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Riboflavin Kinase Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Riboflavin Kinase Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Feed Grade
Table 4. Major Players of Food Grade
Table 5. Major Players of Pharma Grade
Table 6. Global Riboflavin Kinase Sales by Type (2017-2022) & (Tons)
Table 7. Global Riboflavin Kinase Sales Market Share by Type (2017-2022)
Table 8. Global Riboflavin Kinase Revenue by Type (2017-2022) & ($ million)
Table 9. Global Riboflavin Kinase Revenue Market Share by Type (2017-2022)
Table 10. Global Riboflavin Kinase Sale Price by Type (2017-2022) & (US$/Ton)
Table 11. Global Riboflavin Kinase Sales by Application (2017-2022) & (Tons)
Table 12. Global Riboflavin Kinase Sales Market Share by Application (2017-2022)
Table 13. Global Riboflavin Kinase Revenue by Application (2017-2022)
Table 14. Global Riboflavin Kinase Revenue Market Share by Application (2017-2022)
Table 15. Global Riboflavin Kinase Sale Price by Application (2017-2022) & (US$/Ton)
Table 16. Global Riboflavin Kinase Sales by Company (2020-2022) & (Tons)
Table 17. Global Riboflavin Kinase Sales Market Share by Company (2020-2022)
Table 18. Global Riboflavin Kinase Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Riboflavin Kinase Revenue Market Share by Company (2020-2022)
Table 20. Global Riboflavin Kinase Sale Price by Company (2020-2022) & (US$/Ton)
Table 21. Key Manufacturers Riboflavin Kinase Producing Area Distribution and Sales Area
Table 22. Players Riboflavin Kinase Products Offered
Table 23. Riboflavin Kinase Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Riboflavin Kinase Sales by Geographic Region (2017-2022) & (Tons)
Table 27. Global Riboflavin Kinase Sales Market Share Geographic Region (2017-2022)
Table 28. Global Riboflavin Kinase Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Riboflavin Kinase Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Riboflavin Kinase Sales by Country/Region (2017-2022) & (Tons)
Table 31. Global Riboflavin Kinase Sales Market Share by Country/Region (2017-2022)
Table 32. Global Riboflavin Kinase Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Riboflavin Kinase Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Riboflavin Kinase Sales by Country (2017-2022) & (Tons)
Table 35. Americas Riboflavin Kinase Sales Market Share by Country (2017-2022)
Table 36. Americas Riboflavin Kinase Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Riboflavin Kinase Revenue Market Share by Country (2017-2022)
Table 38. Americas Riboflavin Kinase Sales by Type (2017-2022) & (Tons)
Table 39. Americas Riboflavin Kinase Sales Market Share by Type (2017-2022)
Table 40. Americas Riboflavin Kinase Sales by Application (2017-2022) & (Tons)
Table 41. Americas Riboflavin Kinase Sales Market Share by Application (2017-2022)
Table 42. APAC Riboflavin Kinase Sales by Region (2017-2022) & (Tons)
Table 43. APAC Riboflavin Kinase Sales Market Share by Region (2017-2022)
Table 44. APAC Riboflavin Kinase Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Riboflavin Kinase Revenue Market Share by Region (2017-2022)
Table 46. APAC Riboflavin Kinase Sales by Type (2017-2022) & (Tons)
Table 47. APAC Riboflavin Kinase Sales Market Share by Type (2017-2022)
Table 48. APAC Riboflavin Kinase Sales by Application (2017-2022) & (Tons)
Table 49. APAC Riboflavin Kinase Sales Market Share by Application (2017-2022)
Table 50. Europe Riboflavin Kinase Sales by Country (2017-2022) & (Tons)
Table 51. Europe Riboflavin Kinase Sales Market Share by Country (2017-2022)
Table 52. Europe Riboflavin Kinase Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Riboflavin Kinase Revenue Market Share by Country (2017-2022)
Table 54. Europe Riboflavin Kinase Sales by Type (2017-2022) & (Tons)
Table 55. Europe Riboflavin Kinase Sales Market Share by Type (2017-2022)
Table 56. Europe Riboflavin Kinase Sales by Application (2017-2022) & (Tons)
Table 57. Europe Riboflavin Kinase Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Riboflavin Kinase Sales by Country (2017-2022) & (Tons)
Table 59. Middle East & Africa Riboflavin Kinase Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Riboflavin Kinase Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Riboflavin Kinase Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Riboflavin Kinase Sales by Type (2017-2022) & (Tons)
Table 63. Middle East & Africa Riboflavin Kinase Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Riboflavin Kinase Sales by Application (2017-2022) & (Tons)
Table 65. Middle East & Africa Riboflavin Kinase Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Riboflavin Kinase
Table 67. Key Market Challenges & Risks of Riboflavin Kinase
Table 68. Key Industry Trends of Riboflavin Kinase
Table 69. Riboflavin Kinase Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Riboflavin Kinase Distributors List
Table 72. Riboflavin Kinase Customer List
Table 73. Global Riboflavin Kinase Sales Forecast by Region (2023-2028) & (Tons)
Table 74. Global Riboflavin Kinase Sales Market Forecast by Region
Table 75. Global Riboflavin Kinase Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Riboflavin Kinase Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Riboflavin Kinase Sales Forecast by Country (2023-2028) & (Tons)
Table 78. Americas Riboflavin Kinase Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Riboflavin Kinase Sales Forecast by Region (2023-2028) & (Tons)
Table 80. APAC Riboflavin Kinase Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Riboflavin Kinase Sales Forecast by Country (2023-2028) & (Tons)
Table 82. Europe Riboflavin Kinase Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Riboflavin Kinase Sales Forecast by Country (2023-2028) & (Tons)
Table 84. Middle East & Africa Riboflavin Kinase Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Riboflavin Kinase Sales Forecast by Type (2023-2028) & (Tons)
Table 86. Global Riboflavin Kinase Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Riboflavin Kinase Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Riboflavin Kinase Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Riboflavin Kinase Sales Forecast by Application (2023-2028) & (Tons)
Table 90. Global Riboflavin Kinase Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Riboflavin Kinase Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Riboflavin Kinase Revenue Market Share Forecast by Application (2023-2028)
Table 93. DSM Basic Information, Riboflavin Kinase Manufacturing Base, Sales Area and Its Competitors
Table 94. DSM Riboflavin Kinase Product Offered
Table 95. DSM Riboflavin Kinase Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 96. DSM Main Business
Table 97. DSM Latest Developments
Table 98. BASF Basic Information, Riboflavin Kinase Manufacturing Base, Sales Area and Its Competitors
Table 99. BASF Riboflavin Kinase Product Offered
Table 100. BASF Riboflavin Kinase Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 101. BASF Main Business
Table 102. BASF Latest Developments
Table 103. NB Group Basic Information, Riboflavin Kinase Manufacturing Base, Sales Area and Its Competitors
Table 104. NB Group Riboflavin Kinase Product Offered
Table 105. NB Group Riboflavin Kinase Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 106. NB Group Main Business
Table 107. NB Group Latest Developments
Table 108. Shanghai Acebright Pharmaceuticals Basic Information, Riboflavin Kinase Manufacturing Base, Sales Area and Its Competitors
Table 109. Shanghai Acebright Pharmaceuticals Riboflavin Kinase Product Offered
Table 110. Shanghai Acebright Pharmaceuticals Riboflavin Kinase Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 111. Shanghai Acebright Pharmaceuticals Main Business
Table 112. Shanghai Acebright Pharmaceuticals Latest Developments
Table 113. Hubei Guangji Pharmaceutical Basic Information, Riboflavin Kinase Manufacturing Base, Sales Area and Its Competitors
Table 114. Hubei Guangji Pharmaceutical Riboflavin Kinase Product Offered
Table 115. Hubei Guangji Pharmaceutical Riboflavin Kinase Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 116. Hubei Guangji Pharmaceutical Main Business
Table 117. Hubei Guangji Pharmaceutical Latest Developments
Table 118. Ningxia Qiyuan Pharma Basic Information, Riboflavin Kinase Manufacturing Base, Sales Area and Its Competitors
Table 119. Ningxia Qiyuan Pharma Riboflavin Kinase Product Offered
Table 120. Ningxia Qiyuan Pharma Riboflavin Kinase Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 121. Ningxia Qiyuan Pharma Main Business
Table 122. Ningxia Qiyuan Pharma Latest Developments
Table 123. Hebei Shengxue Dacheng Basic Information, Riboflavin Kinase Manufacturing Base, Sales Area and Its Competitors
Table 124. Hebei Shengxue Dacheng Riboflavin Kinase Product Offered
Table 125. Hebei Shengxue Dacheng Riboflavin Kinase Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 126. Hebei Shengxue Dacheng Main Business
Table 127. Hebei Shengxue Dacheng Latest Developments
Table 128. Xinfa Pharmaceutical Basic Information, Riboflavin Kinase Manufacturing Base, Sales Area and Its Competitors
Table 129. Xinfa Pharmaceutical Riboflavin Kinase Product Offered
Table 130. Xinfa Pharmaceutical Riboflavin Kinase Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 131. Xinfa Pharmaceutical Main Business
Table 132. Xinfa Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Riboflavin Kinase
Figure 2. Riboflavin Kinase Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Riboflavin Kinase Sales Growth Rate 2017-2028 (Tons)
Figure 7. Global Riboflavin Kinase Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Riboflavin Kinase Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Feed Grade
Figure 10. Product Picture of Food Grade
Figure 11. Product Picture of Pharma Grade
Figure 12. Global Riboflavin Kinase Sales Market Share by Type in 2021
Figure 13. Global Riboflavin Kinase Revenue Market Share by Type (2017-2022)
Figure 14. Riboflavin Kinase Consumed in Food Additives
Figure 15. Global Riboflavin Kinase Market: Food Additives (2017-2022) & (Tons)
Figure 16. Riboflavin Kinase Consumed in Animal Feeding
Figure 17. Global Riboflavin Kinase Market: Animal Feeding (2017-2022) & (Tons)
Figure 18. Riboflavin Kinase Consumed in Pharmaceutical
Figure 19. Global Riboflavin Kinase Market: Pharmaceutical (2017-2022) & (Tons)
Figure 20. Riboflavin Kinase Consumed in Health Supplements
Figure 21. Global Riboflavin Kinase Market: Health Supplements (2017-2022) & (Tons)
Figure 22. Riboflavin Kinase Consumed in Cosmetic And Personal Care
Figure 23. Global Riboflavin Kinase Market: Cosmetic And Personal Care (2017-2022) & (Tons)
Figure 24. Riboflavin Kinase Consumed in Others
Figure 25. Global Riboflavin Kinase Market: Others (2017-2022) & (Tons)
Figure 26. Global Riboflavin Kinase Sales Market Share by Application (2017-2022)
Figure 27. Global Riboflavin Kinase Revenue Market Share by Application in 2021
Figure 28. Riboflavin Kinase Revenue Market by Company in 2021 ($ Million)
Figure 29. Global Riboflavin Kinase Revenue Market Share by Company in 2021
Figure 30. Global Riboflavin Kinase Sales Market Share by Geographic Region (2017-2022)
Figure 31. Global Riboflavin Kinase Revenue Market Share by Geographic Region in 2021
Figure 32. Global Riboflavin Kinase Sales Market Share by Region (2017-2022)
Figure 33. Global Riboflavin Kinase Revenue Market Share by Country/Region in 2021
Figure 34. Americas Riboflavin Kinase Sales 2017-2022 (Tons)
Figure 35. Americas Riboflavin Kinase Revenue 2017-2022 ($ Millions)
Figure 36. APAC Riboflavin Kinase Sales 2017-2022 (Tons)
Figure 37. APAC Riboflavin Kinase Revenue 2017-2022 ($ Millions)
Figure 38. Europe Riboflavin Kinase Sales 2017-2022 (Tons)
Figure 39. Europe Riboflavin Kinase Revenue 2017-2022 ($ Millions)
Figure 40. Middle East & Africa Riboflavin Kinase Sales 2017-2022 (Tons)
Figure 41. Middle East & Africa Riboflavin Kinase Revenue 2017-2022 ($ Millions)
Figure 42. Americas Riboflavin Kinase Sales Market Share by Country in 2021
Figure 43. Americas Riboflavin Kinase Revenue Market Share by Country in 2021
Figure 44. United States Riboflavin Kinase Revenue Growth 2017-2022 ($ Millions)
Figure 45. Canada Riboflavin Kinase Revenue Growth 2017-2022 ($ Millions)
Figure 46. Mexico Riboflavin Kinase Revenue Growth 2017-2022 ($ Millions)
Figure 47. Brazil Riboflavin Kinase Revenue Growth 2017-2022 ($ Millions)
Figure 48. APAC Riboflavin Kinase Sales Market Share by Region in 2021
Figure 49. APAC Riboflavin Kinase Revenue Market Share by Regions in 2021
Figure 50. China Riboflavin Kinase Revenue Growth 2017-2022 ($ Millions)
Figure 51. Japan Riboflavin Kinase Revenue Growth 2017-2022 ($ Millions)
Figure 52. South Korea Riboflavin Kinase Revenue Growth 2017-2022 ($ Millions)
Figure 53. Southeast Asia Riboflavin Kinase Revenue Growth 2017-2022 ($ Millions)
Figure 54. India Riboflavin Kinase Revenue Growth 2017-2022 ($ Millions)
Figure 55. Australia Riboflavin Kinase Revenue Growth 2017-2022 ($ Millions)
Figure 56. Europe Riboflavin Kinase Sales Market Share by Country in 2021
Figure 57. Europe Riboflavin Kinase Revenue Market Share by Country in 2021
Figure 58. Germany Riboflavin Kinase Revenue Growth 2017-2022 ($ Millions)
Figure 59. France Riboflavin Kinase Revenue Growth 2017-2022 ($ Millions)
Figure 60. UK Riboflavin Kinase Revenue Growth 2017-2022 ($ Millions)
Figure 61. Italy Riboflavin Kinase Revenue Growth 2017-2022 ($ Millions)
Figure 62. Russia Riboflavin Kinase Revenue Growth 2017-2022 ($ Millions)
Figure 63. Middle East & Africa Riboflavin Kinase Sales Market Share by Country in 2021
Figure 64. Middle East & Africa Riboflavin Kinase Revenue Market Share by Country in 2021
Figure 65. Egypt Riboflavin Kinase Revenue Growth 2017-2022 ($ Millions)
Figure 66. South Africa Riboflavin Kinase Revenue Growth 2017-2022 ($ Millions)
Figure 67. Israel Riboflavin Kinase Revenue Growth 2017-2022 ($ Millions)
Figure 68. Turkey Riboflavin Kinase Revenue Growth 2017-2022 ($ Millions)
Figure 69. GCC Country Riboflavin Kinase Revenue Growth 2017-2022 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Riboflavin Kinase in 2021
Figure 71. Manufacturing Process Analysis of Riboflavin Kinase
Figure 72. Industry Chain Structure of Riboflavin Kinase
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles
Global Graphitized Carbon Black (GCB) Ma..
Graphitized carbon black is a black particle that can be use..
+16467917070US (Toll Free)